Inventor · disambiguated record
Xiuzhen Du
Also filed as: DU XIUZHEN
2 granted patents·6 pending applications·1 citations·filing 2015–2025
31Inventor score
Files withCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD5NANJING BESTZYME BIO ENG CO LTD2NANJING SHUNXIN PHARMACEUTICALS CO LTD OF CHIATAI TIANQING PHARMACEUTICAL GROUP1
Top patents by PatentIndex Score
8 records- 0165US10400228B2Truncated pullulanases, methods of production, and methods of use thereofNANJING BESTZYME BIO ENG CO LTD·Filed 2015·Granted Sep 3, 2019·1 cites·12 claims
- 0259US2025223347A1Antigen binding constructs targeting her2 and uses thereofCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2025·Application pending·0 cites
- 0358US2023242632A1Antigen binding constructs targeting her2 and uses thereofCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2021·Application pending·0 cites
- 0454US2024182592A1Multi-specific antibody targeting bcmaCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2022·Application pending·0 cites
- 0549US2023265181A1Single variable domain and antigen binding molecule binding bcmaCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2021·Application pending·0 cites
- 0649US2023193292A1Bcma-binding single variable structural domain and antigen-binding moleculeCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2021·Application pending·0 cites
- 0741US2022289825A1FUSION PROTEIN TARGETING PD-L1 AND TGF-ß AND USE THEREOFNANJING SHUNXIN PHARMACEUTICALS CO LTD OF CHIATAI TIANQING PHARMACEUTICAL GROUP·Filed 2020·Application pending·0 cites
- 0836US11104909B2α-amylase variant and use thereofNANJING BESTZYME BIO ENG CO LTD·Filed 2017·Granted Aug 31, 2021·0 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when Xiuzhen Du files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →